Log In
Print this Print this

Testim, testosterone

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionTopical 1% testosterone gel
Molecular Target Androgen receptor
Mechanism of ActionAndrogen receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism; Treat hypogonadism in HIV-positive men who did not have adequate releif with AndroGel treatment; Treat hypogonadism in men
Regulatory Designation


Bayer AG; Endo International plc; Ipsen Group; Xstelos Holdings Inc.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today